Serum OX40 ligand as a biochemical regulator of Th2-dominant immune activation in asthma: An integrated cytokine network analysis.

Zhu Z, Li S

Open source

DOI
10.5937/jomb0-64381
Published
2026 Jun 16
Container
Journal of medical biochemistry
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.5937/jomb0-64381,
  title = {Serum OX40 ligand as a biochemical regulator of Th2-dominant immune activation in asthma: An integrated cytokine network analysis.},
  author = {Zhu Z and Li S},
  year = {2026},
  journal = {Journal of medical biochemistry},
  doi = {10.5937/jomb0-64381},
  url = {https://doi.org/10.5937/jomb0-64381}
}

RIS

TY  - JOUR
TI  - Serum OX40 ligand as a biochemical regulator of Th2-dominant immune activation in asthma: An integrated cytokine network analysis.
AU  - Zhu Z
AU  - Li S
PY  - 2026
JO  - Journal of medical biochemistry
DO  - 10.5937/jomb0-64381
UR  - https://doi.org/10.5937/jomb0-64381
ER  - 

APA

Z, Z., & S, L. (2026). Serum OX40 ligand as a biochemical regulator of Th2-dominant immune activation in asthma: An integrated cytokine network analysis.. Journal of medical biochemistry. https://doi.org/10.5937/jomb0-64381

Source records